HIV & AIDS

Combination therapy targets latent reservoir of HIV

With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus (HIV) remains a major global epidemic. Existing antiretroviral drugs do not cure ...

HIV & AIDS

Study shows how HIV is shielded from immune attack

Scientists from UNSW Sydney and the UK have discovered that the human immunodeficiency virus (HIV) hijacks a small molecule from the host cell to protect itself from being destroyed by the host's immune system.

HIV & AIDS

A 'public' target for HIV

Individuals produce unique sets of antibodies in response to HIV infection. That diversity—and the ability of the human immunodeficiency virus to rapidly change its protein coat to avoid detection—has stymied efforts ...

Diseases, Conditions, Syndromes

Early HIV treatment key to avoiding brain atrophy

While the human immunodeficiency virus (HIV) has largely dropped from news headlines since the 1990s, at the end of 2016 there were 36.7 million people living with the infection, and of those only 53 per cent had access to ...

Diseases, Conditions, Syndromes

Researchers reveal new way to potentially fight Ebola

More than 11,000 people died during the Ebola outbreak in West Africa from 2013-16, demonstrating both the deadly nature of the virus and the limitations of the medication used to fight it.

page 13 from 40